Dr. Mark R. Drzala is a Summit, New Jersey based male orthopedic surgeon who is specialized in Orthopaedic Surgery of the Spine. Active license number of Dr. Mark R. Drzala is MA058233 for Orthopaedic Surgery of the Spine in New Jersey.
Dr. Mark R. Drzala deals with the evaluation and nonoperative and operative treatment of the full spectrum of primary spinal disorders including trauma, degenerative, deformity, tumor, and reconstructive.
Complete Profile:
Dr. Mark R. Drzala speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Orthopedic - Orthopaedic Surgery of the Spine
Credentials:
M.D.
Gender:
Male
Practice Address:
33 Overlook Rd, Suite 305, Summit, New Jersey, 07901-3570
Phone:
908-608-9610
Fax:
908-608-9611
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1538261250
NPI Enumeration Date:
02 Sep, 2006
NPI Last Update On:
22 Apr, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark R. Drzala are as mentioned below.
License Number
Specialization
State
Status
MA058233
Orthopaedic Surgery of the Spine
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 370, Summit, New Jersey
Zip:
07902-0370
Phone Number:
908-608-9610
Fax Number:
908-608-9611
Patients can reach Dr. Mark R. Drzala at 33 Overlook Rd, Suite 305, Summit, New Jersey or can call to book an appointment on 908-608-9610. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.